Raele Leticia Adriana, the Interim CFO of Algorhythm Holdings, Inc., has reported a significant stock option grant that enables her to acquire over one million shares of the company's common stock. This move is noteworthy as it reflects a strategic initiative to align the interests of key executives with those of shareholders.
The filing, made on October 7, 2026, reveals that Adriana received a non-qualified stock option to purchase 1,144,552 shares of Algorhythm's common stock. Of these, 286,138 shares were vested in full on the date of grant, while the remaining 858,414 shares will vest in equal quarterly installments over the next two years, starting from September 15, 2026.
Background
Algorhythm Holdings, Inc. operates in the technology services sector, specifically focusing on computer integrated systems design. The company is incorporated in Delaware and is publicly traded under the ticker symbol RIME. Recent filings indicate that the company is actively engaging in strategies to enhance employee motivation and retention through equity incentives.
What the Filing Says
The reported transaction involved the Reporting Person's receipt of a non-qualified stock option to purchase 1,144,552 shares of the Issuer's common stock.
This stock option grant is part of the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan, which aims to motivate and retain key personnel by linking their compensation to the company's performance.
Impact
This development may have implications for both the company and its competitors in the technology services industry. By offering substantial stock options, Algorhythm is positioning itself to attract and retain top talent, which could influence how other companies in the sector structure their own compensation packages.
What's Next
The filing does not say what happens next.